-+ 0.00%
-+ 0.00%
-+ 0.00%

*Processa Pharma Enters Research Collaboration of Novel, Oral Macrocyclic Peptide-Based Neonatal Fc Receptor Antagonist Program From Generian Pharma >PCSA

Dow Jones·10/29/2026 12:09:00

Please log in to view news